about
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung CancerProblems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancerLung Cancer Gene Signatures and Clinical PerspectivesThe Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell LinesQuantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancersPrognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapyQuantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment.Testing the metal of ERCC2 in predicting the response to platinum-based therapyHeterogeneity of excision repair cross-complementation group 1 gene expression in non-small-cell lung cancer patients.Prognostic value of EGFR mutation and ERCC1 in patients with non-small cell lung cancer undergoing platinum-based chemotherapyGemcitabine sensitivity factors, hENT1 and RRM1 as potential prognostic biomarker for advanced biliary tract cancer.Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions.A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development.The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survivalThe Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients withAntiangiogenic agents and chemotherapy in advanced non-small cell lung cancer: a clinical perspective.Precision treatment for cancer: role of prognostic and predictive markers.Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC.Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape.ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency.p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma.Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer.[Novel morphological and molecular aspects of lung cancer].The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer.Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair.
P2860
Q27853293-15684001-7A2B-417A-BBCD-E1F2DB2F8DABQ28069810-3863A83F-F865-4D72-B967-1B7F8101F8DDQ28387769-266C3787-3B85-4494-A201-EFAF61540A35Q28547067-27128DC3-F11A-432A-8995-9543B290DB69Q30579903-42927E80-559E-4142-8E46-9F329D533B8AQ33727749-F8E5A7F8-9212-4C6E-B1FF-CB8A1B7DB1B5Q33914197-D74A2552-2938-46AA-BF2E-A7CC1F4F645CQ34290072-7B7A334A-D0F4-4C93-BBE3-32FBA3314F71Q34607731-0965A253-1447-4905-A168-882149F23E8EQ34937417-322293B0-99F2-4354-B0D4-1216324B0B45Q35017050-834E32B6-33CD-4F58-AD5A-C880542E7A30Q35275675-B329BC88-5A50-4FEA-8886-48E126768A1CQ35917450-19B6C3FC-C51D-4BB4-A637-609E28AD04D2Q37225452-7422EEA4-502B-4316-B57A-7CC808574DBBQ37626124-1790934E-3A3A-4DD4-9443-F02F030B2347Q38153445-CD455B00-78EF-4FB9-9208-4B2608348F52Q38179024-BBB06DF7-2FF4-41D4-90E8-FD234E7D740BQ38575758-F6D5BEDE-0312-410F-9ACA-92F55F0EDED3Q38922208-DC7E49FE-8C4B-4FB2-A3D3-226B12D19F70Q39012252-78F3615E-96CE-4917-9FFC-5428BCF98370Q40382947-5FEAE5A9-5277-4A96-B025-595D6FF2D642Q41318869-58AF5F63-E8AB-48BE-B31C-6B50CC222336Q45264604-9E7B417F-BFB8-44C1-AFC0-9ACB1E58C25EQ47110861-CBF9671A-B066-4F05-8971-04808976BA9BQ52584335-4013DD28-ABC6-40BF-8E4D-0CCDE9EE3AD4Q52775079-E109E7FA-18FF-4F06-8B69-5190CBB63C39Q55286515-3C5ACF5B-9468-4B7E-9388-2BFD3F757916
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
ERCC1 and RRM1: ready for prime time?
@en
type
label
ERCC1 and RRM1: ready for prime time?
@en
prefLabel
ERCC1 and RRM1: ready for prime time?
@en
P356
P1476
ERCC1 and RRM1: ready for prime time?
@en
P2093
Benjamin Besse
Ken A Olaussen
P304
P356
10.1200/JCO.2012.43.0900
P407
P577
2013-02-11T00:00:00Z